| Identification | Back Directory | [Name]
2-Oxazolidinone, 5-(2-chlorophenyl)-4-[5-(2-phenylethynyl)-3-pyridinyl]-, (4R,5R)- | [CAS]
1375752-78-5 | [Synonyms]
2-Oxazolidinone, 5-(2-chlorophenyl)-4-[5-(2-phenylethynyl)-3-pyridinyl]-, (4R,5R)- | [Molecular Formula]
C22H15ClN2O2 | [MOL File]
1375752-78-5.mol | [Molecular Weight]
374.82 |
| Chemical Properties | Back Directory | [Boiling point ]
619.6±55.0 °C(Predicted) | [density ]
1.38±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
10.61±0.60(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Uses]
BMS-984923, a potent mGluR5 silent allosteric modulator (SAM), with exquisite binding affinity (Ki = 0.6 nM), exhibits good oral bioavailability and BBB penetration. BMS-984923 potently inhibits the PrPC-mGluR5 interaction and prevents pathological Aβo signaling without affecting physiological glutamate signaling[1][2]. | [in vivo]
BMS-984923 (7.5 mg/kg or 15 mg/kg, oral gavage, once) exhibits good oral bioavailability and BBB penetration[1].
| Animal Model: | C57Bl6J male mice[1]. | | Dosage: | 7.5 mg/kg or 15 mg/kg (Pharmacokinetic Analysis) | | Administration: | Oral gavage, once. | | Result: | The plasma concentration exceeded 2 μM at 10 hr. Brain concentrations were nearly as high as plasma concentrations when measured 3 hr after a 7.5 mg/kg oral dose |
| [References]
[1] Laura T Haas, et al. Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer's Mouse Phenotypes. Cell Rep. 2017 Jul 5;20(1):76-88. DOI:10.1016/j.celrep.2017.06.023
[2] Hong Huang, et al. Oxazolidinone-based allosteric modulators of mGluR5: Defining molecular switches to create a pharmacological tool box. Bioorg Med Chem Lett. 2016 Sep 1;26(17):4165-9. DOI:10.1016/j.bmcl.2016.07.065 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|